Skip to main content

SOLARA · Solara Active Pharma Sciences Limited · Documents

690.60 INR +15.30 (+2.27%) At close · Nov 13
Volume · Nov 13 15.13K Avg daily vol (3M) 26.75K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 16, 2026
2026
Oct 16
Earnings call
Q2 2027 earnings call

Solara Active Pharma Sciences Limited reported revenue growth of 33% year-on-year, base-business revenue growth of 37% to 327 crores, and EBITDA margin expansion to 18.4% from 11%. It expects to close the ibuprofen strategic review in 12 weeks.

Showing 1–3 of 3 documents